3 Results for "

E3810

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "E3810" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-15391
CAS No.: 1058137-23-7
Purity:  98.94%
Synonyms: E-3810
Target:  

VEGFR FGFR

Research Areas:  

Cancer

Lucitanib (E-3810) is a novel dual inhibitor of VEGFR and FGFR, potently and selectively inhibits VEGFR1, VEGFR2, VEGFR3, FGFR1 and FGFR2 with IC50s of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15391A
CAS No.: 2108875-91-6
Target:  

VEGFR FGFR

Research Areas:  

Cancer

Lucitanib (E-3810) dihydrochloride is a novel dual inhibitor of VEGFR and FGFR, potently and selectively inhibits VEGFR1, VEGFR2, VEGFR3, FGFR1 and FGFR2 with IC50s of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively .
loading...
    loading...
Cat. No.: HY-15391R
CAS No.: 1058137-23-7
Synonyms: E-3810 (Standard)
Research Areas:  

Cancer

Lucitanib (Standard) is the analytical standard of Lucitanib. This product is intended for research and analytical applications. Lucitanib (E-3810) is a novel dual inhibitor of VEGFR and FGFR, potently and selectively inhibits VEGFR1, VEGFR2, VEGFR3, FGFR1 and FGFR2 with IC50s of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively .
loading...
    loading...